Selinexor Combined With Reduced-Dose Radiotherapy For Early-Stage Extranodal NK/T-Cell Lymphoma
Clinical trial NCT07554482 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07554482
- Sponsor
- Beijing Tongren Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-15
- Primary completion
- 2027-12-31
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.